Scott A. Smith
Chief Executive OfficerViatris
PharmaceuticalsView Profile →Chief Executive Officer · Zoetis
Kristin Peck leads Zoetis after building its U.S. commercial business and earlier serving in business development and strategy leadership at Pfizer.
Last reviewed: Nov 2, 2026
Chief Executive Officer
Zoetis
Last Reviewed: November 2, 2026
Kristin Peck leads Zoetis after building its U.S. commercial business and earlier serving in business development and strategy leadership at Pfizer.
Peck’s early career included private equity and real estate finance work at Prudential Realty Group, the O’Connor Group and J.P. Morgan. She later became a principal at Boston Consulting Group, where she worked from 1999 to 2004.
She joined Pfizer in 2004 and advanced through strategic planning, a chief of staff assignment and worldwide business development leadership. As executive vice president of worldwide business development and innovation, she served on Pfizer’s executive leadership team and evaluated strategic alternatives for its animal health and nutrition businesses.
Peck joined Zoetis’ founding executive team in 2012. Her early portfolio included manufacturing and supply, poultry, diagnostics, new product marketing and global market research. She moved into leadership of U.S. operations in 2015, overseeing launches including Simparica and Cytopoint and investing in customer loyalty programs, digital tools and direct-to-consumer marketing.
In 2018, she added corporate strategy and business development. That work included the acquisitions of diagnostics company Abaxis and nutritional products business Platinum Performance. She became CEO on January 1, 2020, succeeding Juan Ramón Alaix, after joining the board in October 2019.
Peck’s outside leadership includes the boards of BlackRock, Mayo Clinic and Business Roundtable. Her earlier professional service included the Thomson Reuters board and Columbia Business School’s Deming Center advisory board, alongside mentoring women building careers in animal health.